Results 51 to 60 of about 291,495 (261)
Private demand for cholera vaccines in Beira, Mozambique.
, 2007 In the summer of 2005, we interviewed 996 randomly selected respondents in Beira, Mozambique concerning their willingness and ability to pay for cholera vaccine for themselves and for other household members.
Whittington, Dale +10 more
core +1 more source
Polysaccharide determination in protein/polysaccharide mixtures for phase-diagram construction [PDF]
, 2010 The effect of protein removal from protein–polysaccharide mixtures on the determination of total sugar concentration for phase-diagram construction was explored by response surface methodology.
Agbenorhevi, Jacob K. +1 more
core +1 more source
Vaccine against Streptococcus suis Infection in Pig Based on Alternative Carrier Protein Conjugate
Vaccines, 2022 Streptococcus suis is a serious pathogen in the pig industry with zoonotic potential. With respect to the current effort to reduce antibiotic use in animals, a prophylactic measure is needed to control the disease burden.
Natalie Kralova +14 more
doaj +1 more source
Vaccines against cholera, typhoid fever and shigellosis for developing countries.
, 2004 Enteric diseases, such as cholera, typhoid fever and shigellosis, still produce a significant burden, especially among the poor in countries where these illnesses are endemic.
Ochiai, RL +7 more
core +1 more source
Review of meningococcal vaccines with updates on immunization in adults [PDF]
, 2014 Meningococcal disease is a serious and global life-threatening disease. Six serogroups (A, B, C, W-135, X, and Y) account for the majority of meningococcal disease worldwide.
Dbaibo, Ghassan S. +3 more
core +1 more source
Meningococcal polysaccharide-protein conjugate vaccines [PDF]
, 1997 Meningococcal oligosaccharide- and polysaccharide-protein conjugate vaccines are under investigation in humans for prevention of disease caused by serogroup A and C organisms. These vaccines appear to be safe and well tolerated.
Forrest, Bruce +2 more
core +1 more source
Food and Agricultural Immunology, 2021 Inactivated foot-and-mouth disease (FMD) vaccines generally require adjuvants to enhance the immunogenicity. To test whether the aqueous extracts of Cistanche deserticola (AECD) could be developed into a polysaccharide adjuvant for inactivated FMD ...
Ailian Zhang +6 more
doaj +1 more source
Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.
, 2005 BACKGROUND: Decisions about the use of killed oral cholera vaccines, which confer moderate levels of direct protection to vaccinees, can depend on whether the vaccines also provide indirect (herd) protection when high levels of vaccine coverage are ...
Ali, Mohammad +10 more
core +1 more source
Development of Streptococcus pneumoniae Vaccines Using Live Vectors [PDF]
, 2015 : Streptococcus pneumoniae still causes severe morbidity and mortality worldwide, especially in young children and the elderly. Much effort has been dedicated to developing protein-based universal vaccines to conquer the current shortcomings of capsular ...
core +1 more source
Advanced Healthcare Materials, EarlyView.Biologically derived and hybrid nonviral nanovectors are examined as distinct but convergent design approaches. Integrating synthetic components with biologically functionalized membranes allows efficient interactions with complex cellular environments.
Clara Baldari +10 more
wiley +1 more source